{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:11:41Z","timestamp":1784243501115,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015190","name":"Houston Methodist Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajt.2026.02.026","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:58:48Z","timestamp":1772096328000},"page":"1577-1584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personal viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetes"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3244-8710","authenticated-orcid":false,"given":"Katafan","family":"Achkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0928-2860","authenticated-orcid":false,"given":"Fawaz","family":"Al Ammary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-695X","authenticated-orcid":false,"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-2037","authenticated-orcid":false,"given":"Tim","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-3500","authenticated-orcid":false,"given":"Archana R.","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-4974","authenticated-orcid":false,"given":"Ahmed Osama","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajt.2026.02.026_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/ajt.12625","article-title":"Estimating risks of de novo kidney diseases after living kidney donation","volume":"14","author":"Steiner","year":"2014","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2026.02.026_bib2","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/ajt.13917","article-title":"Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors","volume":"16","author":"Anjum","year":"2016","journal-title":"Am J Transplant"},{"issue":"1 Suppl 1","key":"10.1016\/j.ajt.2026.02.026_bib3","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajt.2026.02.026_bib4","article-title":"Organ Procurement and Transplantation Network (OPTN) Policies","year":"2025","journal-title":"Health Resources and Services Administration"},{"issue":"5","key":"10.1016\/j.ajt.2026.02.026_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4093\/dmj.2021.0220","article-title":"Assessment of insulin secretion and insulin resistance in human","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"issue":"8","key":"10.1016\/j.ajt.2026.02.026_bib6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/oby.23503","article-title":"Measuring and estimating insulin resistance in clinical and research settings","volume":"30","author":"Gastaldelli","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.ajt.2026.02.026_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ajt.2026.02.026_bib8","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ajt.2026.02.026_bib9","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3390\/jcm9113451","article-title":"The oral glucose tolerance test\u2014is it time for a change?\u2014A literature review with an emphasis on pregnancy","volume":"9","author":"Bogdanet","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.ajt.2026.02.026_bib10","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1210\/clinem\/dgad135","article-title":"Reproducibility of glycemic measures among dysglycemic youth and adults in the RISE study","volume":"108","author":"Tjaden","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajt.2026.02.026_bib11","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.2147\/DMSO.S246062","article-title":"The oral glucose tolerance test: 100 years later","volume":"13","author":"Jagannathan","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.ajt.2026.02.026_bib12","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.2337\/dc10-2201","article-title":"Two-step approach for the prediction of future type 2 diabetes risk","volume":"34","author":"Abdul-Ghani","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ajt.2026.02.026_bib13","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2337\/dc11-1902","article-title":"Impaired glucose tolerance and obesity as effect modifiers of ethnic disparities of the progression to diabetes","volume":"35","author":"Lorenzo","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.ajt.2026.02.026_bib14","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","article-title":"What is the best predictor of future type 2 diabetes?","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajt.2026.02.026_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111636","article-title":"International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"210","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.ajt.2026.02.026_bib16","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/dc20-1688","article-title":"Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis","volume":"44","author":"Ahuja","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajt.2026.02.026_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc17-1351","article-title":"Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study","volume":"41","author":"Pareek","year":"2018","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ajt.2026.02.026_bib18","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2015-2573","article-title":"One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose","volume":"100","author":"Fiorentino","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ajt.2026.02.026_bib19","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajt.2026.02.026_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diabres.2016.08.013","article-title":"One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension","volume":"120","author":"Bergman","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.ajt.2026.02.026_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","article-title":"Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis","volume":"56","author":"Morris","year":"2013","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ajt.2026.02.026_bib22","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1172\/JCI129188","article-title":"\u03b2 Cell dysfunction during progression of metabolic syndrome to type 2 diabetes","volume":"129","author":"Hudish","year":"2019","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ajt.2026.02.026_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome","volume":"30","author":"Meigs","year":"2007","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ajt.2026.02.026_bib24","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jc.2010-1698","article-title":"Role of glycated hemoglobin in the prediction of future risk of T2DM","volume":"96","author":"Abdul-Ghani","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ajt.2026.02.026_bib25","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db07-0954","article-title":"Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test","volume":"57","author":"Festa","year":"2008","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ajt.2026.02.026_bib26","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2337\/diab.44.12.1386","article-title":"Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans","volume":"44","author":"Haffner","year":"1995","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ajt.2026.02.026_bib27","doi-asserted-by":"crossref","first-page":"e3278","DOI":"10.1210\/clinem\/dgab198","article-title":"Lean (pre)diabetes\u2014underestimated and underexplored","volume":"106","author":"Pfeiffer","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ajt.2026.02.026_bib28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ajt.2026.02.026_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.TP.0000438625.91095.8b","article-title":"Prediabetic living kidney donors have preserved kidney function at 10 years after donation","volume":"97","author":"Chandran","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2026.02.026_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/TP.0000000000003665","article-title":"Outcomes of kidney donors with impaired fasting glucose","volume":"106","author":"Hebert","year":"2022","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2026.02.026_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2215\/CJN.09460822","article-title":"Accepting living kidney donors with preexisting diabetes mellitus: a perspective on the recent OPTN policy change\u2014July 2022","volume":"18","author":"Soliman","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2026.02.026_bib32","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/ajt.14416","article-title":"Renal consequences of diabetes after kidney donation","volume":"17","author":"Ibrahim","year":"2017","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.02.026_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/ajt.14671","article-title":"Causes and timing of end-stage renal disease after living kidney donation","volume":"18","author":"Matas","year":"2018","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:57:08Z","timestamp":1784242628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1600613526001127"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.02.026","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personal viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}